Modigene to Present at the Roth 2007 New York Investor ...( - Presentation to be We...)

- Presentation to be Webcast Live and Archived -

VIENNA, Va., Aug. 29 /PRNewswire-FirstCall/ -- Modigene Inc. (OTC Bulletin Board: MODG) today announced that senior management will present at the Roth 2007 New York Investor Conference on Thursday, September 6, 2007 at 3:00 pm EDT. The conference will be held at the Westin New York at Times Square in New York City.

Modigene CEO Abraham Havron and President Shai Novik will provide a company overview and review of corporate developments.

"As a relatively new public company, we look forward to this opportunity to inform additional investors about our innovative technology that has the potential to significantly extend the duration of virtually any therapeutic protein drug," noted Dr. Havron. "We believe our product pipeline has great clinical and commercial promise as a result of our ability to increase the utility and convenience of a wide range of protein therapeutics currently used by millions of patients each year."

The Modigene presentation will be webcast live and can be accessed by visiting http://www.wsw.com/webcast/roth13/modigene/. An archived version of the presentation webcast will also be available following the conclusion of the conference at the same address for approximately 90 days.

For more information about the Roth 2007 New York Investor Conference, visit http://www.roth.com/main/Page.aspx?PageID=7015.

ABOUT MODIGENE

Modigene Inc. (OTC Bulletin Board: MODG) is a biopharmaceutical company applying its patented CTP technology to develop longer-acting, proprietary versions of already approved therapeutic proteins that currently generate billions of dollars in annual global sales. Modigene is currently developing long-acting versions of human growth hormone, erythropoietin, interferon beta, and GLP-1,
'/>"/>